Dibutyryl-cGMP sodium is a cell-permeable cGMP analog that preferentially activates cGMP-dependent protein kinase (PKG); it inhibits [3H]-arachidonic acid release in γ-thrombin-stimulated human platelets; exhibits analgesic effects by activating ATP-sensitive K+ channels; induces process elongation and branching in astrocytes through rapid, reversible, and concentration-dependent redistribution of glial fibrillary acidic protein (GFAP) and actin filaments; prevents stress fiber formation and promotes stellate morphology in cerebellar astrocytes; inhibits RhoA membrane association; accelerates wound closure in a scratch wound model; antagonizes PGE2-induced hyperalgesia in a dose-dependent manner in vivo.